GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Accounts Payable

Veritas In Silico (TSE:130A) Accounts Payable : 円0.0 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Accounts Payable?

Veritas In Silico's Accounts Payable for the quarter that ended in Jun. 2024 was 円0.0 Mil.


Veritas In Silico Accounts Payable Historical Data

The historical data trend for Veritas In Silico's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Accounts Payable Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23
Accounts Payable
- - -

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24
Accounts Payable Get a 7-Day Free Trial - - - - -

Veritas In Silico Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Veritas In Silico Accounts Payable Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines